Welcome to LookChem.com Sign In|Join Free

CAS

  • or

937263-42-8

Post Buying Request

937263-42-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

937263-42-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 937263-42-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,7,2,6 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 937263-42:
(8*9)+(7*3)+(6*7)+(5*2)+(4*6)+(3*3)+(2*4)+(1*2)=188
188 % 10 = 8
So 937263-42-8 is a valid CAS Registry Number.

937263-42-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(imidazo[1,2-a]pyridin-7-yloxy)-3-methylbenzenamine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:937263-42-8 SDS

937263-42-8Downstream Products

937263-42-8Relevant articles and documents

[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS

-

Page/Page column 50; 52, (2021/10/30)

The present invention relates to new [1,3]diazino[5,4-d]pyrimidines and derivatives of Formula (I), wherein the groups R1, R2, R3 and R4 have the meanings given in the claims and specification, their use as inhibitors of HER2 and its mutants, pharmaceutical compositions which contain such compounds and their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases.

ERBB RECEPTOR INHIBITORS

-

Page/Page column 58; 59, (2019/11/28)

Disclosed are compounds inhibiting ErbBs (e. g. HER2), pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat diseases associated ErbBs (especially HER2), including cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 937263-42-8